Orthopedic implant maker restor3d has launched MyFit by restor3d, a patient-engagement platform that follows people through the full arc of a 3D-printed joint replacement — from the moment a personalized implant is designed through years of recovery afterward. The company announced the platform on September 8, 2026, positioning it less as a marketing add-on than as the connective tissue between its manufacturing pipeline and the long-term clinical evidence that payers and surgeons increasingly demand.
MyFit bundles three pieces that, until now, have mostly lived in separate systems at most orthopedic practices: MyFit Connect, which sends automated SMS updates to hip and knee patients at key milestones — enrollment, design, manufacturing, and surgery readiness; a separate patient portal that gives shoulder, foot, and ankle patients implant-status updates along with an interactive 3D visualization of their personalized implant design; and a five-year prospective outcomes registry that will track patient-reported results at defined intervals after surgery. restor3d says the registry is targeting enrollment of roughly 2,250 patients spanning hip, knee, shoulder, and foot-and-ankle procedures — the same anatomical range the company already serves with its personalized implant lines.
A Digital Layer on Top of a Personalization Pipeline
restor3d's core business is building implants matched to individual patient anatomy, generated from imaging data and produced using additive manufacturing. That workflow already requires a digital model of the patient's joint before a single patient-specific implant component gets printed. For shoulder, foot, and ankle patients, MyFit's portal essentially reuses that existing design data and puts a simplified, patient-facing 3D visualization of it in front of the person who is about to receive the implant — turning a file that previously lived only in the surgical planning software into something a patient can look at before surgery.
That's a meaningful shift in how implant makers talk to patients directly, rather than exclusively through the surgeon. For hip and knee patients, MyFit Connect's SMS check-ins serve the more conventional function of any care-navigation tool: milestone updates as the implant moves through enrollment, design, and manufacturing toward surgery readiness. But it's the registry piece that carries the most weight for the industry, because it converts one-off patient satisfaction into structured, longitudinal data. A five-year window is long enough to capture not just whether a knee or shoulder replacement worked in the first few months, but whether a personalized, 3D-printed implant continues to perform as well — or better — than an off-the-shelf equivalent years down the line. That's precisely the kind of evidence additive orthopedics has struggled to produce at scale, since personalized-implant volumes have historically been too small and too fragmented across hospitals to generate registry-grade outcomes data.
restor3d's CEO, Kurt Jacobus, said patients undergoing joint replacement are increasingly engaged in their own care and want to better understand the technology designed specifically for them — framing MyFit as a way to keep patients informed rather than leaving them to navigate an implant procedure with limited visibility into what's actually being built for them.
Scale: 520 Surgeons, 740 Hospitals, $104 Million
The launch lands on top of a company that has been expanding fast. restor3d's own announcement cites a network of more than 520 surgeons across 740 hospitals nationwide, a figure the company had already reported as of 2024 — a network large enough that a five-year, multi-anatomy registry is at least plausible to fill without relying on a handful of flagship academic medical centers. restor3d's total funding stands at $104 million following Partners Group's first institutional investment in the company in August 2025, capital that has presumably underwritten both the clinical network expansion and the software build-out that MyFit represents.
Framed against that backdrop, MyFit reads as much like an evidence-generation and retention strategy as a patient-comfort feature. Hospitals and surgeons choosing between a personalized 3D-printed implant and a conventional stock device want outcomes data, not just anatomical-fit arguments. A structured registry baked directly into the patient's own communication channel — rather than a separate research protocol that requires extra staff time to administer — lowers the friction of actually collecting that data at the volumes restor3d's surgeon network can plausibly support.
The launch was covered independently by both 3D Printing Industry and TCT Magazine, published a day apart. TCT's account, published September 9, quotes restor3d describing MyFit as creating "a seamless connection between patients, surgeons, and long-term clinical outcomes" — and quotes Michael Swank, MD, of Imperial Health, framing the platform as a way to connect patient experience, technology, and outcomes into one continuous thread rather than three disconnected touchpoints.
What It Means for Makers
Most FilamentFeed readers won't ever touch a restor3d implant directly, but the launch is a useful data point for anyone tracking how additive manufacturing moves from prototyping novelty to regulated, evidence-backed production medicine. The pattern here — pairing a personalized 3D-printed part with a structured, long-term data-collection system wrapped around the person who receives it — is a template that other medical-device and even consumer-adjacent 3D-printed product categories (custom orthotics, dental appliances, prosthetics) are likely to follow as they mature past small-batch novelty into reimbursed, insurance-scrutinized product lines. It's also a reminder that the "3D-printed" part of a medical device story is often the least interesting piece once the device reaches commercial scale; the harder, more valuable work increasingly happens in the software and data layer that proves the printed part was worth making in the first place.
For makers building a business around personalized or on-demand printed goods — whether orthopedic, dental, or otherwise — MyFit is a concrete example of what "outcomes accountability" looks like once a 3D-printed product graduates from a single custom job to a repeatable clinical product line: a five-year data commitment, not just a one-time fit check.
